(WEX) Wex - Ratings and Ratios
Fleet Cards, Corporate Payments, Benefits SaaS
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 28.7% |
| Value at Risk 5%th | 43.0% |
| Relative Tail Risk | -8.98% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.22 |
| Alpha | -32.72 |
| CAGR/Max DD | -0.03 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.377 |
| Beta | 1.407 |
| Beta Downside | 1.523 |
| Drawdowns 3y | |
|---|---|
| Max DD | 53.15% |
| Mean DD | 19.56% |
| Median DD | 16.88% |
Description: WEX Wex November 06, 2025
WEX Inc. (NYSE: WEX) runs a diversified commerce platform that serves three primary markets. The Mobility segment delivers fleet-vehicle payment processing, account-management, and analytics services to commercial fleets and government agencies, using both direct sales and co-branded/private-label partnerships. The Corporate Payments segment offers embedded payment, accounts-payable automation, and spend-management tools to customers in travel, fintech, insurance, consumer-bill-pay, and media verticals. The Benefits Solutions segment provides a SaaS platform for consumer-directed health-benefit administration-including HSA/HSAs, COBRA, and enrollment services-distributed through third-party administrators, payroll providers, and health plans.
Key quantitative signals (as of FY 2023) include total revenue of $2.2 billion, a 9 % year-over-year growth rate, and an adjusted EBITDA margin of roughly 24 %, reflecting the high-margin nature of SaaS-driven services. The Mobility business is sensitive to corporate fleet-spending trends and the ongoing shift toward electric-vehicle (EV) fleets, which could expand the addressable market by an estimated $15 billion over the next five years (based on industry forecasts). Meanwhile, the Benefits Solutions line benefits from rising employer adoption of consumer-directed health plans, a sector that has grown at a compound annual rate of 12 % since 2020.
For a deeper quantitative assessment, you may find ValueRay’s platform useful for benchmarking WEX against peers and exploring scenario-based valuations.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (283.8m TTM) > 0 and > 6% of Revenue (6% = 157.5m TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA 1.23pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 17.61% (prev 14.74%; Δ 2.87pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 798.0m > Net Income 283.8m (YES >=105%, WARN >=100%) |
| Net Debt (4.21b) to EBITDA (916.3m) ratio: 4.60 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.05 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (34.8m) change vs 12m ago -12.56% (target <= -2.0% for YES) |
| Gross Margin 59.06% (prev 60.98%; Δ -1.92pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 18.49% (prev 19.02%; Δ -0.53pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.63 (EBITDA TTM 916.3m / Interest Expense TTM 239.2m) >= 6 (WARN >= 3) |
Altman Z'' 1.19
| (A) 0.03 = (Total Current Assets 9.72b - Total Current Liabilities 9.25b) / Total Assets 14.43b |
| (B) 0.16 = Retained Earnings (Balance) 2.29b / Total Assets 14.43b |
| (C) 0.04 = EBIT TTM 630.0m / Avg Total Assets 14.20b |
| (D) 0.16 = Book Value of Equity 2.15b / Total Liabilities 13.31b |
| Total Rating: 1.19 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 66.80
| 1. Piotroski 4.0pt |
| 2. FCF Yield 12.58% |
| 3. FCF Margin 24.48% |
| 4. Debt/Equity 4.49 |
| 5. Debt/Ebitda 4.60 |
| 6. ROIC - WACC (= 0.96)% |
| 7. RoE 25.82% |
| 8. Rev. Trend 79.61% |
| 9. EPS Trend 44.75% |
What is the price of WEX shares?
Over the past week, the price has changed by -0.01%, over one month by +6.61%, over three months by -9.40% and over the past year by -13.66%.
Is WEX a buy, sell or hold?
- Strong Buy: 2
- Buy: 1
- Hold: 13
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the WEX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 176.9 | 15% |
| Analysts Target Price | 176.9 | 15% |
| ValueRay Target Price | 152.5 | -0.9% |
WEX Fundamental Data Overview December 03, 2025
P/E Trailing = 19.0481
P/E Forward = 8.4175
P/S = 1.9137
P/B = 4.5485
P/EG = 1.4028
Beta = 1.029
Revenue TTM = 2.62b USD
EBIT TTM = 630.0m USD
EBITDA TTM = 916.3m USD
Long Term Debt = 3.72b USD (from longTermDebt, last quarter)
Short Term Debt = 1.31b USD (from shortTermDebt, last quarter)
Debt = 5.03b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.21b USD (from netDebt column, last quarter)
Enterprise Value = 5.11b USD (5.02b + Debt 5.03b - CCE 4.94b)
Interest Coverage Ratio = 2.63 (Ebit TTM 630.0m / Interest Expense TTM 239.2m)
FCF Yield = 12.58% (FCF TTM 642.6m / Enterprise Value 5.11b)
FCF Margin = 24.48% (FCF TTM 642.6m / Revenue TTM 2.62b)
Net Margin = 10.81% (Net Income TTM 283.8m / Revenue TTM 2.62b)
Gross Margin = 59.06% ((Revenue TTM 2.62b - Cost of Revenue TTM 1.07b) / Revenue TTM)
Gross Margin QoQ = 60.35% (prev 58.64%)
Tobins Q-Ratio = 0.35 (Enterprise Value 5.11b / Total Assets 14.43b)
Interest Expense / Debt = 1.27% (Interest Expense 63.8m / Debt 5.03b)
Taxrate = 31.10% (36.2m / 116.4m)
NOPAT = 434.1m (EBIT 630.0m * (1 - 31.10%))
Current Ratio = 1.05 (Total Current Assets 9.72b / Total Current Liabilities 9.25b)
Debt / Equity = 4.49 (Debt 5.03b / totalStockholderEquity, last quarter 1.12b)
Debt / EBITDA = 4.60 (Net Debt 4.21b / EBITDA 916.3m)
Debt / FCF = 6.56 (Net Debt 4.21b / FCF TTM 642.6m)
Total Stockholder Equity = 1.10b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.97% (Net Income 283.8m / Total Assets 14.43b)
RoE = 25.82% (Net Income TTM 283.8m / Total Stockholder Equity 1.10b)
RoCE = 13.08% (EBIT 630.0m / Capital Employed (Equity 1.10b + L.T.Debt 3.72b))
RoIC = 6.99% (NOPAT 434.1m / Invested Capital 6.21b)
WACC = 6.04% (E(5.02b)/V(10.05b) * Re(11.20%) + D(5.03b)/V(10.05b) * Rd(1.27%) * (1-Tc(0.31)))
Discount Rate = 11.20% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -8.87%
[DCF Debug] Terminal Value 71.46% ; FCFE base≈565.3m ; Y1≈682.3m ; Y5≈1.11b
Fair Price DCF = 333.8 (DCF Value 11.44b / Shares Outstanding 34.3m; 5y FCF grow 22.11% → 3.0% )
EPS Correlation: 44.75 | EPS CAGR: 16.61% | SUE: 1.26 | # QB: 2
Revenue Correlation: 79.61 | Revenue CAGR: 9.19% | SUE: 0.87 | # QB: 1
EPS next Quarter (2026-03-31): EPS=3.99 | Chg30d=-0.056 | Revisions Net=+2 | Analysts=12
EPS next Year (2026-12-31): EPS=17.67 | Chg30d=+0.064 | Revisions Net=+6 | Growth EPS=+10.9% | Growth Revenue=+4.3%
Additional Sources for WEX Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle